11:10 AM EST, 02/05/2025 (MT Newswires) -- European equities traded in the US as American depositary receipts were trending sharply higher late Wednesday morning, rising 1.36% to 1,375.76 on the S&P Europe Select ADR Index.

From continental Europe, the gainers were led by internet advertising firm Criteo ( CRTO ) and financial services company Banco Santander (SAN), which advanced 21% and 8.2%, respectively. They were followed by pharmaceutical company Novo Nordisk ( NVO ) and biopharmaceutical company Genfit ( GNFT ) , which increased 5% and 4.6%, respectively.

The decliners from continental Europe were led by petroleum refiner Equinor ( EQNR ) and biopharmaceutical company DBV Technologies ( DBVT ) , which dropped 3.7% and 2.4%, respectively. They were followed by furniture maker Natuzzi (NTZ) and financial services company ING (ING), which were off 0.2% and 0.1%, respectively.

From the UK and Ireland, the gainers were led by pharmaceutical companies GSK (GSK) and Silence Therapeutics ( SLN ) , which rose 7.5% and 2.5%, respectively. They were followed by tobacco company British American Tobacco ( BTI ) and biopharmaceutical company Akari Therapeutics ( AKTX ) , which were up 2% and 1.7%, respectively.

The decliners from the UK and Ireland were led by biotech firm Trinity Biotech ( TRIB ) and biopharmaceutical company TC Biopharm ( TCBP ) , which lost 5.9% and 3.8%, respectively. They were followed by alcoholic beverage company Diageo ( DEO ) and biotech firm Autolus Therapeutics ( AUTL ) , which were down 2.9% and 0.9%, respectively.